Gossamer Bio, Inc. (FRA:4GB)
Germany flag Germany · Delayed Price · Currency is EUR
2.118
-0.330 (-13.48%)
Jan 26, 2026, 4:00 PM EST

Gossamer Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-156.16-56.53-179.82-229.38-234-243.36
Depreciation & Amortization
1.854.154.394.435.174.27
Other Amortization
0.971.091.321.166.733.86
Loss (Gain) From Sale of Assets
0.190.810.73-0.02-
Asset Writedown & Restructuring Costs
7.48-100.070.0823.38
Loss (Gain) From Sale of Investments
-9.56-13.06-9.45-1.410.34-0.16
Stock-Based Compensation
12.6220.6228.5242.5532.0138.75
Change in Accounts Receivable
-2.66-5.34----
Change in Accounts Payable
-4.49-1.663.99-1.81-4.436.98
Change in Unearned Revenue
-13.0555.92----
Change in Other Net Operating Assets
4.38-9.47-18.83-2.655.2-10.08
Operating Cash Flow
-158.43-3.47-159.16-187.03-188.89-176.36
Capital Expenditures
-0.08---0.41-1.55-1.5
Sale (Purchase) of Intangibles
----0.07-0.08-23.38
Investment in Securities
136.529.02-110.97-0.56-115.81240.23
Investing Cash Flow
136.4229.02-110.97-1.04-117.43215.34
Long-Term Debt Issued
-----193.6
Long-Term Debt Repaid
--12.58-11.61-5.81--
Net Debt Issued (Repaid)
--12.58-11.61-5.81-193.6
Issuance of Common Stock
2.470.63201.77122.93.33118.94
Other Financing Activities
-0.46----
Financing Cash Flow
2.47-11.49190.15117.093.33312.54
Foreign Exchange Rate Adjustments
0.01-0.10.11-0.52-0.170.01
Net Cash Flow
-19.5313.97-79.86-71.49-303.15351.53
Free Cash Flow
-158.51-3.47-159.16-187.44-190.44-177.86
Free Cash Flow Margin
-359.84%-3.02%----
Free Cash Flow Per Share
-0.70-0.01-1.04-2.22-2.54-2.60
Cash Interest Paid
1010.5612.2912.7112.747.87
Levered Free Cash Flow
-82-16.7-84.66-99.55-99.82-119.24
Unlevered Free Cash Flow
-76.12-10.59-77.54-92.04-94.4-115.18
Change in Working Capital
-15.8239.46-14.84-4.460.77-3.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.